Search by Drug Name or NDC

    NDC 64764-0918-18 ULORIC 40 mg/1 Details

    ULORIC 40 mg/1

    ULORIC is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is FEBUXOSTAT.

    Product Information

    NDC 64764-0918
    Product ID 64764-918_fecf6101-9a35-4781-bea4-e7b92b4afb81
    Associated GPIs 68000030000320
    GCN Sequence Number 064829
    GCN Sequence Number Description febuxostat TABLET 40 MG ORAL
    HIC3 C7A
    HIC3 Description HYPERURICEMIA TX - XANTHINE OXIDASE INHIBITORS
    GCN 16808
    HICL Sequence Number 036106
    HICL Sequence Number Description FEBUXOSTAT
    Brand/Generic Brand
    Proprietary Name ULORIC
    Proprietary Name Suffix n/a
    Non-Proprietary Name febuxostat
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/1
    Substance Name FEBUXOSTAT
    Labeler Name Takeda Pharmaceuticals America, Inc.
    Pharmaceutical Class Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021856
    Listing Certified Through 2024-12-31

    Package

    NDC 64764-0918-18 (64764091818)

    NDC Package Code 64764-918-18
    Billing NDC 64764091818
    Package 500 TABLET in 1 BOTTLE (64764-918-18)
    Marketing Start Date 2009-02-13
    NDC Exclude Flag N
    Pricing Information N/A